Pseudomonas EGYARMY-FU-2025
The Pseudomonas EGYARMY-FU-2025 strain was isolated from clinical samples and identified using phenotypic and molecular techniques. Antimicrobial susceptibility testing revealed multidrug resistance to most commonly used antibiotics, with susceptibility retained only to tigecycline and colistin. Whole genome sequencing (WGS) confirmed the high-quality genome assembly and annotation, revealing multiple antimicrobial resistance (AMR) genes and virulence determinants. Genome analysis indicated that the strain harbors diverse resistance mechanisms, including efflux pumps, enzyme inactivation, and antibiotic target modification, which contribute to its extensive drug resistance profile.